On Thursday shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) closed at $4.95. Company’s sales growth for last 5 years was -1.90% and EPS growth for next 5 years is recorded as 25.00%. On 24 April, Valeant Pharma (NYSE: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending a new indication for RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.
Oracle Corporation (NYSE:ORCL) in last trading activity moved down -2.48% to close at $43.62. Company weekly performance is 0.53% while its quarterly performance stands at 2.13%. Oracle Corporation (NYSE:ORCL) is -6.03% away from its 52 week high. Oracle Corporation (NYSE:ORCL) set the stage on 28 April, to become the latest corporation to roll out a multibillion-dollar bond offering, filing plans to sell a series of notes spanning in maturity from seven years to 40. Oracle plans to offer six separate tranches, including notes due in seven years, 10 years, 15 years, 20 years, 30 years and 40 years, according to a prospectus filed with the U.S. Securities and Exchange Commission.
On last trading day Universal Health Services Inc. (NYSE:UHS) moved down -2.31% to close at $116.95. Its volatility for the week is 2.92% while volatility for the month is 2.36%. UHS’s sales growth for past 5 years was 9.20% and its EPS growth for past 5 years was 15.50%. Universal Health Services Inc. (NYSE:UHS) monthly performance is -0.65%. Universal Health Realty Income Trust (NYSE:UHT) announced on 28 April, that for the three-month period ended March 31, 2015, reported net income was $3.7 million, or $.28 per diluted share, as compared to $3.8 million, or $.29 per diluted share, during the first quarter of 2014.
Lattice Semiconductor Corporation (NASDAQ:LSCC) has 0.40% insider ownership while its institutional ownership stands at 94.10%. In last trading activity company’s stock closed at $5.93. Lattice Semiconductor Corporation (NASDAQ:LSCC) announced that it is scheduled to present at the Jefferies 2015 Global Technology, Media and Telecom Conference on Tuesday, May 12th in Miami, Florida. During the conference, Darin G. Billerbeck, President and Chief Executive Officer, and Joe Bedewi, Corporate Vice President and Chief Financial Officer, will be presenting.
On last trading day Marrone Bio Innovations, Inc. (NASDAQ:MBII) moved down -7.48% to close at $3.34. Its volatility for the week is 8.80% while volatility for the month is 6.50%. Marrone Bio Innovations, Inc. (NASDAQ:MBII) monthly performance is -13.70%. Marrone Bio Innovations, Inc. (NASDAQ:MBII) on 23 April, said the accounting problems that have cast a heavy shadow over the company lasted longer into 2014 than initially thought.